Medtronic plc (NYSE: MDT) reported third quarter 2023 earnings outcomes at the moment.
Income of $7.7 billion was flat as reported and up 4.1% organically in comparison with the identical interval a 12 months in the past.
GAAP web revenue decreased 17% year-over-year to $1.22 billion whereas EPS was down 16% to $0.92. Adjusted EPS of $1.30 was down 4% YoY.
The corporate expects natural income development of 4.5-5.0% for the fourth quarter of 2022.